Clinical Trial Update: Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Suzetrigine-enhanced multimodal opioid-sparing therapy for postoperative pain in patients undergoing bariatric and cardiac sur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Obesity
• Postoperative Pain

Drugs mentioned

• Suzetrigine-enhanced multimodal opioid-sparing therapy (Suzetrigine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Bariatric Surgery, Cardiac Surgery With Sternotomy | Phase 3 | Status: RECRUITING